Dr. Michiko Inaba, MD

Dr. Inaba practices at Kaiser Permanente Moanalua Medical Center in Honolulu, Hawaii, part of Kaiser Permanente.

Dr. Inaba's NPI, 1083833388, was assigned on April 25, 2007. Dr. Inaba holds Hawaii license MD-14938.

Dr. Inaba's primary practice is Kaiser Permanente Moanalua Medical Center, at 3288 Moanalua Rd, Honolulu, HI 96819 in Honolulu County. The practice phone is (808) 432-0000.

Dr. Inaba's primary practice is Kaiser Permanente Moanalua Medical Center in Honolulu, Hawaii, part of Kaiser Permanente. The medical group on file is Hawaii Permanente Medical Group (HPMG). Dmand AI also links Dr. Inaba to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Inaba practices, 2 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Inaba's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dmand AI has Dr. Inaba's licenses on file in 2 states: Hawaii and Ohio.

CMS data shows 25 Medicare services from Dr. Inaba across 1 procedure code in 2024, all of them office visits, for 21 Medicare patients. Medicare paid $1,583 for them. Every service was in an office.

CMS counts 21 Medicare patients who saw Dr. Inaba in 2024. 71% of them have arthritis. Their average risk score is 0.97, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Inaba's median patient age at 60, with 70% women.

In 2024, Dr. Inaba wrote 1,901 Medicare Part D claims for 333 patients. 70% of them were for generic drugs. CMS names the drug for 1,661 of them, across 34 drugs with 11 or more claims each, at $1,229,613 in total drug cost. In 2023, CMS named 1,550 claims across 31 drugs.

Dr. Inaba accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Inaba as offering telehealth.

Dmand AI links 9 papers to Dr. Inaba, published from 2011 to 2014. 2012 was the busiest year, with 3. The most frequent topics are Nursing Homes, Polypharmacy and Brain. Dr. Inaba has published most often in Clin Geriatr Med. Dr. Inaba's most frequent co-authors are Christina L. Bell, MD, Gotaro Kojima, MD and Robert Abbott, DO.

CMS Open Payments shows 10 general payments to Dr. Inaba from 8 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 86% of the total. Novartis Pharmaceuticals Corporation paid the most, $238.